Ly Tu

6.5k total citations
107 papers, 4.3k citations indexed

About

Ly Tu is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ly Tu has authored 107 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 26 papers in Cardiology and Cardiovascular Medicine and 19 papers in Molecular Biology. Recurrent topics in Ly Tu's work include Pulmonary Hypertension Research and Treatments (83 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers). Ly Tu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (83 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (10 papers). Ly Tu collaborates with scholars based in France, Netherlands and United States. Ly Tu's co-authors include Christophe Guignabert, Marc Humbert, Alice Huertas, Saadia Eddahibi, Élie Fadel, Serge Adnot, David Montani, Raphaël Thuillet, Laurent Savale and Carole Phan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Ly Tu

98 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ly Tu France 35 3.3k 1.4k 1.1k 631 422 107 4.3k
Grażyna Kwapiszewska Austria 38 2.7k 0.8× 836 0.6× 1.4k 1.3× 528 0.8× 506 1.2× 126 4.3k
Laimute Taraseviciene‐Stewart United States 25 3.5k 1.1× 1.0k 0.7× 1.2k 1.2× 547 0.9× 443 1.0× 37 4.6k
Yasunori Kasahara Japan 24 3.3k 1.0× 805 0.6× 977 0.9× 588 0.9× 338 0.8× 80 4.3k
Kimio Satoh Japan 37 1.5k 0.5× 1.3k 1.0× 1.6k 1.5× 522 0.8× 402 1.0× 98 4.0k
Robert Voswinckel Germany 39 3.8k 1.2× 2.1k 1.5× 1.6k 1.5× 1.1k 1.7× 286 0.7× 99 5.8k
Barbara Girerd France 33 3.3k 1.0× 1.4k 1.0× 757 0.7× 542 0.9× 138 0.3× 68 3.9k
Karen A. Fagan United States 30 3.0k 0.9× 1.2k 0.8× 1.1k 1.1× 459 0.7× 194 0.5× 46 4.3k
Georg Hansmann Germany 37 3.0k 0.9× 1.6k 1.1× 1.0k 0.9× 900 1.4× 166 0.4× 127 4.8k
John J. Lepore United States 38 947 0.3× 1.3k 0.9× 2.4k 2.3× 841 1.3× 333 0.8× 61 4.7k
Glenn Marsboom United States 26 1.5k 0.5× 798 0.6× 2.0k 1.8× 356 0.6× 160 0.4× 41 3.7k

Countries citing papers authored by Ly Tu

Since Specialization
Citations

This map shows the geographic impact of Ly Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ly Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ly Tu more than expected).

Fields of papers citing papers by Ly Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ly Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ly Tu. The network helps show where Ly Tu may publish in the future.

Co-authorship network of co-authors of Ly Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Ly Tu. A scholar is included among the top collaborators of Ly Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ly Tu. Ly Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avouac, Jérôme, Anne Cauvet, Morgane Boulch, et al.. (2023). Effects of B Cell Depletion by CD19‐Targeted Chimeric Antigen Receptor T Cells in a Murine Model of Systemic Sclerosis. Arthritis & Rheumatology. 76(2). 268–278. 15 indexed citations
2.
Tu, Ly, Christophe Guignabert, Christopher J. Rhodes, et al.. (2023). Cytokines as Prognostic Biomarkers in Pulmonary Arterial Hypertension. A2513–A2513. 1 indexed citations
3.
Tu, Ly, Raphaël Thuillet, Thomas Beck, et al.. (2023). AMPK activation by metformin protects against pulmonary hypertension in rats and relaxes isolated human pulmonary artery. European Journal of Pharmacology. 946. 175579–175579. 9 indexed citations
4.
Tu, Ly, Raphaël Thuillet, Lionel Nicol, et al.. (2023). Inhibition of Soluble Epoxide Hydrolase Does Not Promote or Aggravate Pulmonary Hypertension in Rats. Cells. 12(4). 665–665. 3 indexed citations
5.
Phan, Carole, Nihel Berrebeh, Raphaël Thuillet, et al.. (2022). Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells. American Journal of Respiratory Cell and Molecular Biology. 67(2). 215–226. 5 indexed citations
6.
Cecon, Erika, Sophie Le Poder, Fernando Real, et al.. (2021). Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2. Journal of Pineal Research. 72(1). e12772–e12772. 24 indexed citations
7.
Chaumais, Marie‐Camille, Raphaël Thuillet, Amélie Cumont, et al.. (2020). Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension. Cardiovascular Research. 117(5). 1391–1401. 34 indexed citations
8.
Klein, Théo, Laurie W. Geenen, Ly Tu, et al.. (2020). Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension. Journal of Clinical Medicine. 9(5). 1248–1248. 9 indexed citations
9.
Tu, Ly, et al.. (2020). Purinergic Dysfunction in Pulmonary Arterial Hypertension. Journal of the American Heart Association. 9(18). e017404–e017404. 14 indexed citations
10.
Huertas, Alice, Ly Tu, Marc Humbert, & Christophe Guignabert. (2019). Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator. Cardiovascular Research. 116(5). 885–893. 94 indexed citations
11.
Bordenave, Jennifer, Raphaël Thuillet, Ly Tu, et al.. (2019). Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Cardiovascular Research. 116(3). 686–697. 59 indexed citations
12.
Boleto, Gonçalo, Christophe Guignabert, Sonia Pezet, et al.. (2018). T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis. Arthritis Research & Therapy. 20(1). 197–197. 37 indexed citations
13.
Szulcek, Robert, Chris Happé, Nina Rol, et al.. (2016). Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension: Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage. American Journal of Respiratory and Critical Care Medicine. 193(12). 1410–1420. 73 indexed citations
14.
Hiress, Morane Le, Ly Tu, Nicolas Ricard, et al.. (2015). Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex. American Journal of Respiratory and Critical Care Medicine. 192(8). 983–997. 147 indexed citations
15.
Freund‐Michel, Véronique, Marcelina Cardoso Dos Santos, Christophe Guignabert, et al.. (2015). Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(3). 342–355. 21 indexed citations
16.
Tu, Ly, Frances S. de Man, Barbara Girerd, et al.. (2012). A Critical Role for p130Cas in the Progression of Pulmonary Hypertension in Humans and Rodents. American Journal of Respiratory and Critical Care Medicine. 186(7). 666–676. 72 indexed citations
17.
Man, Frances S. de, Ly Tu, M. Louis Handoko, et al.. (2012). Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 186(8). 780–789. 252 indexed citations
18.
Tu, Ly, Laurence Dewachter, Élie Fadel, et al.. (2010). Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 45(2). 311–322. 105 indexed citations
19.
Guilluy, Christophe, Saadia Eddahibi, C. Agard, et al.. (2009). RhoA and Rho Kinase Activation in Human Pulmonary Hypertension: Role of 5-HT Signaling. American Journal of Respiratory and Critical Care Medicine. 179(12). 1151–1158. 145 indexed citations
20.
Sanchez, Olivier, Élisabeth Marcos, Frédéric Perros, et al.. (2007). Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 176(10). 1041–1047. 179 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026